[Federal Register Volume 69, Number 92 (Wednesday, May 12, 2004)]
[Notices]
[Page 26407]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-10799]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated December 19, 2003, and published in the Federal 
Register on January 27, 2004, (69 FR 3946), Cedarburg Pharmaceuticals, 
LLC, 870 Badger Circle, Grafton, Wisconsin 53024, made application by 
letter to the Drug Enforcement Administration for registration as a 
bulk manufacturer of Fentanyl (9801), a basic class of Schedule II 
controlled substance.
    The firm plans to manufacture in bulk for distribution to 
customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Cedarburg Pharmaceuticals, LLC, to 
manufacture the listed controlled substance is consistent with the 
public interest at this time. DEA has investigated Cedarburg 
Pharmaceuticals, LLC, to ensure that the company's registration is 
consistent with the public interest. This investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant 
Administrator, Office of Diversion Control, hereby orders that the 
application submitted by the above firm for registration as a bulk 
manufacturer of the basic class of controlled substance listed is 
granted.

    Dated: April 23, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administrator.
[FR Doc. 04-10799 Filed 5-11-04; 8:45 am]
BILLING CODE 4410-09-M